| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHNEUR.1986.00520090022010 |
| P8608 | Fatcat ID | release_6q5j53oxlrgkfb5tg5hijuyzqi |
| P698 | PubMed publication ID | 3488728 |
| P50 | author | Stanley I. Rapoport | Q57269588 |
| James V. Haxby | Q23992770 | ||
| Cheryl L. Grady | Q26722137 | ||
| P2093 | author name string | Duara R | |
| Berg G | |||
| Schlageter N | |||
| P433 | issue | 9 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| dementia | Q83030 | ||
| P304 | page(s) | 882-885 | |
| P577 | publication date | 1986-09-01 | |
| P1433 | published in | Archives of Neurology | Q15766672 |
| P1476 | title | Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia | |
| P478 | volume | 43 |
| Q24186399 | 18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) |
| Q49157195 | 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease |
| Q42529061 | A PET study of Turner's syndrome: effects of sex steroids and the X chromosome on brain. |
| Q46538803 | A new assessment tool for neuropsychopharmacologic research: the Computerized Neuropsychological Test Battery |
| Q52257130 | Abnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET. |
| Q53295731 | Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETa |
| Q40603923 | Alzheimer's disease: fundamental and therapeutic aspects |
| Q48282729 | Alzheimer's disease: metabolic uncoupling of associative brain regions |
| Q55417596 | An investigation of cerebral oxygen utilization, blood flow and cognition in healthy aging. |
| Q26863471 | An update on the role of mitochondrial α-ketoglutarate dehydrogenase in oxidative stress |
| Q42672221 | Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects |
| Q48453334 | Brain Cytochrome Oxidase in Alzheimer's Disease |
| Q59489845 | Brain energy metabolism in Alzheimer’s disease: 99mTc-HMPAO SPECT imaging during verbal fluency and role of astrocytes in the cellular mechanism of 99mTc-HMPAO retention |
| Q48593332 | Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis |
| Q48557999 | Brain single photon emission computed tomography findings in depressive pseudodementia patients |
| Q60010754 | Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts |
| Q51980264 | Characteristics of elderly who develop Alzheimer's disease during the next two years-a neuropsychological study using CAMCOG. The Odense Study. |
| Q40435808 | Clinical brain radionuclide imaging studies |
| Q39645824 | Cognitive and brain imaging measures of Alzheimer's disease |
| Q70259351 | Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia |
| Q48417401 | Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide |
| Q49134222 | Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42. |
| Q53434904 | Cortical source multivariate EEG synchronization analysis on amnestic mild cognitive impairment in type 2 diabetes. |
| Q33735848 | Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET |
| Q53216110 | Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease. |
| Q36820095 | Development of an “early” detection battery for dementia of the Alzheimer type |
| Q36972797 | Diagnostic and pharmacological approaches in Alzheimer's disease |
| Q35254212 | Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? |
| Q43222582 | EEG brain mapping in evaluating the time-course of the central action of DUP 996--a new acetylcholine releasing drug |
| Q34159350 | Early Detection of Brain Pathology Suggestive of Early AD Using Objective Evaluation of FDG‐PET Scans |
| Q48551903 | Effect of Nucleus Basalis Magnocellularis Ablation on Local Brain Glucose Utilization in the Rat: Functional Brain Reorganization |
| Q30577801 | Emission tomography contribution to clinical neurology |
| Q33836224 | Functional brain imaging in the resting state and during activation in Alzheimer's disease. Implications for disease mechanisms involving oxidative phosphorylation |
| Q35336866 | Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene |
| Q30481762 | How well does structural equation modeling reveal abnormal brain anatomical connections? An fMRI simulation study |
| Q91667072 | Imaging Studies of Aging, Neurodegenerative Disease, and Alcoholism |
| Q41114184 | Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type |
| Q33683205 | Lateral asymmetries in primary degenerative dementia of the Alzheimer type. A correlative study of cognitive, haemodynamic and EEG data, in relation with severity, age of onset and sex. |
| Q52068802 | Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. |
| Q39603354 | Measurement of disease progression in Alzheimer's disease |
| Q28333982 | Memory and attention in patients with senile dementia of the Alzheimer type and in normal elderly subjects |
| Q48671019 | Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease |
| Q50197771 | Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease. |
| Q33585950 | Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease |
| Q37340547 | Mitochondrial bioenergetics is defective in presymptomatic Tg2576 AD mice |
| Q41547386 | Mitochondrial dysfunction in neurodegeneration |
| Q33540918 | Mitochondrial involvement in Alzheimer's disease |
| Q52068314 | Motor vehicle crashes in dementia of the Alzheimer type. |
| Q39518558 | Neuroplasticity and the progression of Alzheimer's disease |
| Q48225534 | Neuroprotective activity of acetyl-L-carnitine: studies in vitro |
| Q34570703 | Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease |
| Q38461160 | Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type |
| Q40701195 | Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease |
| Q48870835 | Pathological diagnosis of Alzheimer-type dementia for old-old and oldest-old patients |
| Q46253099 | Potential value of quantitative analysis of cerebral PET in early cognitive decline |
| Q33733259 | Primary amnesia of insidious onset with subsequent stabilisation |
| Q39112076 | Proenergetic effects of resveratrol in the murine neuronal cell line Neuro2a |
| Q48870848 | Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex |
| Q48783829 | Quantitative comparison of measurements of cerebral glucose metabolic rate made with two positron cameras |
| Q39606455 | Recent research on the causes of Alzheimer's disease |
| Q52054494 | Recognition memory for words and faces in primary degenerative dementia of the Alzheimer type and normal old age. |
| Q46438245 | Reduced temporal lobe glucose metabolism in aging |
| Q33591546 | Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease |
| Q53216235 | Regional HmPAO SPECT and CT measurements in the diagnosis of Alzheimer's disease. |
| Q38457668 | Regional cerebral blood flow during word and nonword reading |
| Q47185264 | Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type |
| Q53343197 | Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. |
| Q24201440 | The accuracy of 18 FDG-PET in the early diagnosis of Alzheimer’s disease dementia and other dementias in people with MCI |
| Q24539024 | The apolipoprotein E gene, attention, and brain function |
| Q41114461 | The current status of clinical PET imaging |
| Q42521187 | The metabolic pathology of the AIDS dementia complex |
| Q38446238 | The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment |
| Q49110100 | The onset of Alzheimer's disease. A longitudinal case study and a trial of new diagnostic criteria |
| Q48790100 | The ratio of mesial to neocortical temporal lobe blood flow as a predictor of dementia |
| Q42469513 | The topographic distribution of brain atrophy in Alzheimer's disease |
| Q35532399 | The use of positron emission tomography in the clinical assessment of dementia |
| Q48213415 | Topographical analysis of glucose metabolism, as measured with positron emission tomography, in dementia of the Alzheimer type: use of linear histograms |
| Q41096506 | Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease |
| Q52020877 | Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: Correlation with memory functions |
| Q40660449 | What is primary and what secondary for amyloid deposition in Alzheimer's disease |
| Q80027955 | [Brain substrates of episodic memory disorders in Alzheimer's disease] |
Search more.